DiaMedica Inc., a Canadian biopharmaceutical company focused on developing novel treatments for diabetes and neurological disorders, announced the initiation of a type 1 diabetes program following the acquisition of Sanomune. The initiation of this program is based on encouraging preclinical results with DM-99, a naturally occurring protein that the company has previously...
Category: Science
The clear disparity between native, pancreatic insulin and the currently available synthetic insulins leaves a lot to be desired...
Sanofi-aventis and the Juvenile Diabetes Research Foundation (JDRF) announced a unique partnership to develop therapeutic treatments for people with type 1 diabetes at different stages of the disease - both those living with the disease and the newly diagnosed - as well as preventing diabetes in those at risk...
Neurocrine Biosciences and Boehringer Ingelheim to Jointly Research and Develop Type 2 Diabetes Drug
Neurocrine Biosciences, Inc. announcedthat they have established a worldwide collaboration with Boehringer Ingelheim to research and develop small molecule GPR119 agonists for the treatment of type 2 diabetes. The companies will work jointly to identify and advance candidates into pre-clinical development. Boehringer Ingelheim is...
Researchers from the Peninsula Medical School, working in collaboration with colleagues from Glasgow Royal Infirmary and the University of Brighton, have used a unique collection of pancreas specimens taken from patients who died soon after diagnosis of type 1 diabetes to show that they respond to the ongoing process of destruction by inducing their islet cells to proliferate...
The current standard allows a HbA1c measurement to be within 8% – which means that a level of 6.5 could actually be a 6.0 or a 7.0...
Patients with APS are diagnosed based on the co-occurrence of several diseases, such as Addison’s disease, thyroiditis, and Graves’ disease...
Researchers at the University of Insubria in Varese, Italy, have found a significant link between type 1 diabetes and a common virus that usually only causes a mild infection, according to a Reuters report.
The researchers, headed by Antonio Toniolo, studied a small group of 112 children, ages 6-12 with type 1 diabetes. They found that more than 80 percent had evidence of enterovirus infection in their blood....
The artificial pancreas is no longer the jet pack of diabetes, talked about for decades without ever coming to fruition...
The findings of a new study led by Esther Donga, MD of the Leiden University Medical Center in The Netherlands show a short night of sleep has more profound effects on metabolic regulation than previously appreciated. ScienceDaily reports previous studies have found that reductions in sleep duration over multiple nights result...